Testing Status of Polychlorinated biphenyl 10703-H
CASRN: 1336-36-3
Synonyms/Common Names
- 1,1'-Biphenyl, chloro derivatives
Special Studies
- Absorption Distribution Metabolism Excretion (Intravenous)
(S0080)
Completed
- Citation: Lutz RJ, Dedrick RL, Tuey D, Sipes IG, Anderson MW, Matthews HB. Comparison of the pharmacokinetics of several polychlorinated biphenyls in mouse, rat, dog, and monkey by means of a physiological pharmacokinetic model. Drug Metab Dispos. 1984 Sep-Oct;12(5):527-35Pubmed Abstract
- Dogs [D]: Beagles; Monkeys [MO]
- Dose: (intravenous) 0.6 mg/kg [D,MO].
- Absorption Distribution Metabolism Excretion (Intravenous)
(S0736)
Completed
- Citation: Abdel-Hamid FM, Moore JA, Matthews HB. Comparative study of 3,4,3',4'-tetrachlorobiphenyl in male and female rats and female monkeys. J Toxicol Environ Health. 1981 Feb;7(2):181-91.Pubmed Abstract
- Male and Female Rats [R]: CD; Female Monkeys [MO]: Rhesus
- Absorption Distribution Metabolism Excretion (Gavage; Intravenous)
(S0737)
Completed
- Citation: Morales NM, Tuey DB, Colburn WA, Matthews HB. Pharmacokinetics of multiple oral doses of selected polychlorinated biphenyls in mice. Toxicol Appl Pharmacol. 1979 May;48(3):397-407.Pubmed Abstract
- Male Mice [M]: Swiss CD-1
- Dose: (all routes) 0.6 mg/kg [M].
- Metabolism (Intravenous)
(S0056)
Completed
- Citation: Sipes IG, Slocumb ML, Chen HS, Carter DE. 2,3,6,2',3',6'-hexachlorobiphenyl: distribution, metabolism, and excretion in the dog and the monkey. Toxicol Appl Pharmacol. 1982 Feb;62(2):317-24.Pubmed Abstract
- Male Dogs [D]: Beagles; Dogs [D]; Monkeys [MO]; Male Monkeys [MO]
- Metabolism
(S0454)
Completed
- Citation: Duignan DB, Sipes IG, Ciaccio PJ, Halpert JR. The metabolism of xenobiotics and endogenous compounds by the constitutive dog liver cytochrome P450 PBD-2. Arch Biochem Biophys. 1988 Nov 15;267(1):294-304.Pubmed Abstract
- Dogs [D]
- Metabolism (Intravenous)
(S0738)
Completed
- Citation: Tuey DB, Matthews HB. Use of a physiological compartmental model for the rat to describe the pharmacokinetics of several chlorinated biphenyls in the mouse. Drug Metab Dispos. 1980 Nov-Dec;8(6):397-403.Pubmed Abstract
- Male Mice [M]: Swiss CD-1
- Dose: (intravenous) 0.6 mg/kg [M].
- Metabolism
(S0739)
Completed
- Citation: Schnellmann RG, Putnam CW, Sipes IG. Metabolism of 2,2',3,3',6,6'-hexachlorobiphenyl and 2,2',4,4',5,5'-hexachlorobiphenyl by human hepatic microsomes. Biochem Pharmacol. 1983 Nov 1;32(21):3233-9.Pubmed Abstract
- Human (Cell Lines) [HU]
- Metabolism
(S0741)
Completed
- Citation: Garner CE, Jefferson WN, Burka LT, Matthews HB, Newbold RR. In vitro estrogenicity of the catechol metabolites of selected polychlorinated biphenyls. Toxicol Appl Pharmacol. 1999 Jan 15;154(2):188-97.Pubmed Abstract
- []
- Other
(S0506)
Completed
- Citation: McKinney JD, Chae K, McConnell EE, Birnbaum LS. Structure-induction versus structure-toxicity relationships for polychlorinated biphenyls and related aromatic hydrocarbons. Environ Health Perspect. 1985 May;60:57-68.Pubmed Abstract
- []
- Other (Gavage)
(S0740)
Completed
- Citation: Morales NM, Matthews HB. In vivo binding of 2,3,6,2',3',6'-hexachlorobiphenyl and 2,4,5,2',4',5'-hexachlorobiphenyl to mouse liver macromolecules. Chem Biol Interact. 1979 Sep;27(1):99-110.Pubmed Abstract
- Male Mice [M]: Swiss CD-1
- Dose: (gavage) 7.28 mg/kg [M].